Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

✍ Scribed by Brufsky, A.M.

• Book ID: 121937838
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 60 KB
• Volume: 18
• Category: Article
• ISSN: 1043-321X
• DOI: 10.1016/S1043-321X(07)80371-7